# Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

> **NCT02300506** · — · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 507 (actual)

## Conditions studied

- Malignant Glioma

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT02300506
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-10
- **Primary completion:** 2016-07-10
- **Final completion:** 2016-07-10
- **Target enrollment:** 507 (ACTUAL)
- **Last updated:** 2018-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02300506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02300506, "Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02300506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*